Asset Allocation

As of December 31, 2025.
Type % Net
Cash 2.42%
Stock 57.76%
Bond 39.34%
Convertible 0.00%
Preferred 0.00%
Other 0.47%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 73.38%
Mid 19.15%
Small 7.47%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.01%    % Emerging Markets: 0.51%    % Unidentified Markets: 0.47%

Americas 59.83%
59.83%
Canada 39.52%
United States 20.31%
0.00%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 26.13%
United Kingdom 7.61%
18.52%
Denmark 2.14%
Finland 6.28%
France 1.88%
Germany 0.99%
Ireland 1.74%
Switzerland 3.34%
0.00%
0.00%
Greater Asia 13.57%
Japan 8.94%
0.00%
4.39%
Hong Kong 2.58%
Singapore 1.81%
0.23%
China 0.23%
Unidentified Region 0.47%

Bond Credit Quality Exposure

AAA 33.45%
AA 19.88%
A 17.83%
BBB 22.01%
BB 2.45%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 4.38%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
36.93%
Materials
10.59%
Consumer Discretionary
8.57%
Financials
17.76%
Real Estate
0.00%
Sensitive
32.91%
Communication Services
3.22%
Energy
3.19%
Industrials
16.33%
Information Technology
10.16%
Defensive
9.73%
Consumer Staples
1.76%
Health Care
7.96%
Utilities
0.00%
Not Classified
20.44%
Non Classified Equity
0.00%
Not Classified - Non Equity
20.44%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 32.27%
Corporate 35.65%
Securitized 0.00%
Municipal 27.13%
Other 4.95%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
0.14%
Less than 1 Year
0.14%
Intermediate
71.63%
1 to 3 Years
16.05%
3 to 5 Years
15.10%
5 to 10 Years
40.47%
Long Term
27.30%
10 to 20 Years
2.89%
20 to 30 Years
18.12%
Over 30 Years
6.29%
Other
0.93%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial